gonadotropin-releasing hormone analogue


Also found in: Wikipedia.

gonadotropin-releasing hormone analogue

A polypeptide analogue of gonadotropin-releasing hormone–GnRH; some are more potent than GnRH in stimulating gonadotropin release Examples Leuprolide, histrelin, administered in a pulsatile fashion to restore lost GnRH, normalize pituitary-gonadal function, as in congenital GnRH deficiencies–eg, hypogonadotropic hypogonadism with Kallmann syndrome or without anosmia, or in acquired GnRH deficiency secondary to RT of the CNS, pituitary tumors, or panhypopituitarism. See Gonadotropin-releasing hormone.
References in periodicals archive ?
Changes in Body Mass Index in Girls with Idiopathic Central Precocious Puberty under Gonadotropin-Releasing Hormone Analogue Therapy: The Spanish Registry.
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Gonadotropin-releasing hormone analogue has been used in the treatment of CPP for more than 20 years.
Use of new drug delivery formulation of the gonadotropin-releasing hormone analogue deslorelin for reversible long-term contraception in male dogs.
The clinical trials that have been made involving women living with endometriosis for up to 15 months at a low dose, found that the new drug contains the active ingredient, Dienogest and can effectively reduce the pain." He said that the new drug was as effective in treating the disease as a gonadotropin-releasing hormone analogue.
She added that the clinical trials that have been made involving women living with endometriosis for up to 15 months at a low dose found that the new drug that contains the active ingredient, Dienogest, can effectively reduce the pain and is as effective in treating the disease as a gonadotropin-releasing hormone analogue (GnRH-analogue).
Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon downregulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization.
They received Mirena for one year along with monthly injections of a gonadotropin-releasing hormone analogue for six months.
Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity.
All patients underwent surgery and radiation therapy, if needed, plus treatment with the gonadotropin-releasing hormone analogue goserelin 3.6 mg every 28 days to temporarily suppress ovarian function.
All of the women received 6 months of postoperative treatment with the gonadotropin-releasing hormone analogue, triptorelin.
The topics include the secular trend of timing of puberty, the adrenal function of low-birthweight children, the molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome, gonadotropin-releasing hormone analogue treatment for precocious puberty, polycycstic ovary syndrome in adolescence, and present and future options for preserving fertility in female adolescents with cancer.

Full browser ?